Syndromic management of vaginal discharge among women in a reproductive health clinic in India

Sexually Transmitted Infections

Volumn 76, Issue 4, 2000, Pages 303-306

  Vishwanath, Snehalata ^a   Talwar, Vibha ^b   Prasad, Rajendra ^c   Coyaji, Kurus ^d   Elias, Christopher J ^e   De Zoysa, Isabelle ^c  

^a Parivar Seva Sanstha   (India)

^b UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

^c POPULATION COUNCIL   (India)

^d KEM HOSPITAL   (India)

^e POPULATION COUNCIL   (Thailand)

Author keywords

Chlamydia trachomatis; India; Reproductive health; Syndromic approach; Vaginal discharge

Indexed keywords

METRONIDAZOLE;

ALGORITHM; ARTICLE; CHLAMYDIA TRACHOMATIS; CLINICAL PROTOCOL; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HEALTH CARE COST; HUMAN; INDIA; INFECTION RATE; INFECTION RISK; MAJOR CLINICAL STUDY; NEISSERIA GONORRHOEAE; PRIORITY JOURNAL; RISK ASSESSMENT; SYNDROME; SYPHILIS; TRICHOMONAS VAGINALIS; TRICHOMONIASIS; UTERINE CERVICITIS; VAGINA DISCHARGE; VALIDATION PROCESS;

ALGORITHMS; AMBULATORY CARE; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; HUMANS; INDIA; PREVALENCE; SENSITIVITY AND SPECIFICITY; VAGINAL DISCHARGE;

EID: 0033811855     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.76.4.303     Document Type: Article

References (13)

1. 1 Hawkes S, Morison L, Foster S, ct al. Reproductive-tract infections in women in low-income, low-prevalence situations:assessment of -syndromic management in Matlab, Bangladesh. Lancet 1999;354:1776-81.
2. 2 Dallabetta GA, Gerbase AC, Holmes KK. Problems, solutions, and challenges in syndromic management of sexually transmitted diseases. Sex Transm Inf 1998;74 (Suppl 1):S1-11.
3. 3 Addiss DG, Vaughn ML, Golubjatnikov R, et al. Chlamydia trachomatis infection in women attending urban Midwestern family planning and community health clinics: risk factors, selective screening, and evaluation of non-culture techniques. Sex Transm Dis 1990;17:138 46.
4. 4 Handsfield HH, Jasman LL, Roberts PL, et al. Criteria for selective screening for Chlamydia trachomatis infection in women attending family planning clinics. JAMA 1986;255: 1730-4.
5. 5 Mertz KJ, Levine WC, Mosure DJ, et al. Screening women for gonorrhea: demographic screening criteria for general clinical use. Am J Public Health 1997;87:1535-8.
6. 6 Miller WC. Screening for chlamydial infection: a model based on prevalence. Sex Transm Dis 1998;25:201-10.
7. 7 Haberland N, Winikoff B, Sloan N, et al. Case finding and case management of chlamydia and gonorrhea injections among women:what we do and do not know. New York: The Population Council (Robert H Ebert Program on Critical Issues in Reproductive Health), 1999.
8. 8 Paavonen J, Teisala K, Heinonen PK, et al. Microbiological and histopathological findings in acute pelvic inflammatory disease. Br J Obstet Gynaecol 1987;94:454-60.
9. 9 Hauth JC, Goldenberg RL, Andrews WW, et al. Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis. N Eng J Med 1995;333:1732-6.
10. 10 McDonald HM, O'Loughlin JA, Vigneswaran R, et al. Impact of metronidaxole therapy on preterm birth in women with bacterial vaginosis flora (Gardnerella vaginalis):a randomised, placebo controlled trial. Br J Obstet Gynaecol 1997;104:1 391-7.
11. 11 Wasserheit JN. The significance and scope of reproductive tract infections among Third World women. Int J Gynecol Obstet 1989;Suppl 3:145-68.
12. 12 Cohen CR, Duerr A, Pruithithada N, et al. Bacterial vaginosis and HTV seroprevalence among female commercial sex workers in Chiang Mai, Thailand. AIDS 1995;9:1093-7.
13. 13 Schmid G, Markowitz L, Joesoef R, et al. Bacterial vaginosis and HIV infection. Sex Transm Inf 2000;76:3-4.